EcoR1 Capital

Intellia Therapeutics

Cambridge

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Kura Oncology

San Diego

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

Immunome

Bothell

Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.

CRISPR Therapeutics

Boston

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

Janux Therapeutics

San Diego

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

Artiva Biotherapeutics

San Diego

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

SpringWorks Therapeutics

Stamford

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Tectonic Therapeutic

Watertown

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

AnaptysBio

San Diego

AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.

Dicerna Pharmaceuticals

Lexington

Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease.